INTERNATIONAL PATENT: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM FILES APPLICATION FOR "CD70 TARGETING IN CANCER WITH ACQUIRED RESISTANCE TO TARGETED THERAPEUTIC AGENTS"

GENEVA, June 25 -- BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (210 West 7th StreetAustin, Texas 78701) filed a patent application (PCT/US2024/059869) for "CD70 TARGETING IN CANCER WITH ACQUIRED RESISTANCE TO TARGETED THERAPEUTIC AGENTS" on Dec 12, 2024. With publication no. WO/2025/128880, the details related to the patent application was published on Jun 19, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HEYMACH, John Victor (c/o BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM210 West 7th StreetAustin, Texas 78701), NILSSON, Monique B. (c/o BOARD OF REGENTS, THE UNIVERSITY OF TEXAS ...